Additional Effects of Expiration or Termination. If this Agreement expires or is terminated pursuant to Section 10.2(a)(i) (Alvogen breach), Section 10.2(a)(ii) (Alvogen Insolvency), Section 10.2(b)(ii) (Pfenex Insolvency), Section 10.2(b)(iv) (Late Transfer Effective Date), Section 10.2(b)(v) (Excessive Regulatory Costs), or Section 10.2(b)(vi) (One Year Notice), then:
Additional Effects of Expiration or Termination. Survival. Expiration or termination of this Agreement shall not relieve the Parties of any obligation (including any payment obligation) accruing prior to such expiration or termination. Any expiration or termination of this Agreement shall be without prejudice to the rights of either Party against the other accrued or accruing under this Agreement prior to expiration or termination, including the obligation to pay royalties for Product or Compound sold prior to such expiration or termination. In addition, the provisions of Article 1, Article 4, Article 6, Article 7, Article 8, Article 9 and Article 10, and Sections 2.6.1, 2.6.2, 2.7, 2.9, 2.12, 3.1.3, 3.1.5, 3.1.6, 3.1.9, 3.2 (solely to the extent addressing termination by Pfizer pursuant to Section 8.3.1), 3.6, 5.7, 5.8, 5.9, 5.10, 5.11, 5.12 and 5.13, shall survive any expiration or termination of this Agreement.
Additional Effects of Expiration or Termination. Expiration or termination for any reason of this TSA will not relieve the Parties of any liability or obligation which accrued hereunder prior to the effective date of such termination or expiration, nor preclude either Party from pursuing all rights and remedies it may have hereunder or under Applicable Law or in equity.
Additional Effects of Expiration or Termination. If this Agreement expires in its entirety, is terminated in its entirety by NRx pursuant to Section 10.2(a)(i)(1) (Alvogen Insolvency), or is terminated in its entirety by Alvogen pursuant to Section 10.2(b)(iv) (Late Milestones) or Section 10.2(b)(v) (Convenience), then:
Additional Effects of Expiration or Termination
